Cargando…
P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430544/ http://dx.doi.org/10.1097/01.HS9.0000972484.02679.4e |
_version_ | 1785090989650608128 |
---|---|
author | Martinez-Cibrian, Nuria Betriu, Sergi Ortiz-Maldonado, Valentín Esteban, Daniel Tovar, Natalia Triguero Moreno, Ana Alserawan, Leticia Montoro, Mercedes Van Muyden, Anna Spoon, Maike Pont, Margot Jacques, Christian Delgado, Julio |
author_facet | Martinez-Cibrian, Nuria Betriu, Sergi Ortiz-Maldonado, Valentín Esteban, Daniel Tovar, Natalia Triguero Moreno, Ana Alserawan, Leticia Montoro, Mercedes Van Muyden, Anna Spoon, Maike Pont, Margot Jacques, Christian Delgado, Julio |
author_sort | Martinez-Cibrian, Nuria |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104305442023-08-17 P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION Martinez-Cibrian, Nuria Betriu, Sergi Ortiz-Maldonado, Valentín Esteban, Daniel Tovar, Natalia Triguero Moreno, Ana Alserawan, Leticia Montoro, Mercedes Van Muyden, Anna Spoon, Maike Pont, Margot Jacques, Christian Delgado, Julio Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430544/ http://dx.doi.org/10.1097/01.HS9.0000972484.02679.4e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Martinez-Cibrian, Nuria Betriu, Sergi Ortiz-Maldonado, Valentín Esteban, Daniel Tovar, Natalia Triguero Moreno, Ana Alserawan, Leticia Montoro, Mercedes Van Muyden, Anna Spoon, Maike Pont, Margot Jacques, Christian Delgado, Julio P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION |
title | P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION |
title_full | P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION |
title_fullStr | P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION |
title_full_unstemmed | P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION |
title_short | P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION |
title_sort | p1399: initial clinical results of euplagia-1, a phase 1/2 trial of point-of-care manufactured glpg5201 in r/r cll/sll with or without richter’s transformation |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430544/ http://dx.doi.org/10.1097/01.HS9.0000972484.02679.4e |
work_keys_str_mv | AT martinezcibriannuria p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation AT betriusergi p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation AT ortizmaldonadovalentin p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation AT estebandaniel p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation AT tovarnatalia p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation AT trigueromorenoana p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation AT alserawanleticia p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation AT montoromercedes p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation AT vanmuydenanna p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation AT spoonmaike p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation AT pontmargot p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation AT jacqueschristian p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation AT delgadojulio p1399initialclinicalresultsofeuplagia1aphase12trialofpointofcaremanufacturedglpg5201inrrcllsllwithorwithoutrichterstransformation |